Elena Rossi Selected Research

Multiple Abnormalities

10/2013	Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relatives. A review of the Guidelines from Scientific Societies and Working Groups.
6/2008	The risk of symptomatic pulmonary embolism due to proximal deep venous thrombosis differs in patients with different types of inherited thrombophilia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elena Rossi Research Topics

Disease

18	Neoplasms (Cancer) 05/2020 - 11/2003
15	Venous Thromboembolism 01/2019 - 05/2002
14	Thrombophilia 02/2015 - 05/2002
9	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 12/2021 - 03/2007
6	Multiple Myeloma 10/2022 - 07/2006
6	Primary Myelofibrosis (Myelosclerosis) 06/2022 - 08/2019
6	Thrombosis (Thrombus) 01/2019 - 02/2008
6	Breast Neoplasms (Breast Cancer) 12/2011 - 08/2009
5	Venous Thrombosis (Deep-Vein Thrombosis) 10/2022 - 06/2008
5	Hemorrhage 01/2021 - 10/2004
3	Wounds and Injuries (Trauma) 01/2022 - 01/2003
3	Essential Thrombocythemia 01/2022 - 01/2018
3	Splenomegaly 12/2021 - 08/2019
3	Rectal Neoplasms (Rectal Cancer) 11/2008 - 11/2003
3	Colorectal Neoplasms (Colorectal Cancer) 08/2006 - 09/2003
2	Polycythemia Vera 06/2022 - 01/2018
2	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 01/2019
2	Pain (Aches) 04/2021 - 02/2011
2	Bronchiolitis Obliterans Syndrome 01/2021 - 01/2016
2	Philadelphia Chromosome 05/2020 - 05/2012
2	Anemia 01/2020 - 01/2007
2	Disease Progression 01/2019 - 01/2006
2	Parkinson Disease (Parkinson's Disease) 03/2015 - 12/2014
2	Multiple Abnormalities 10/2013 - 06/2008
2	Ovarian Neoplasms (Ovarian Cancer) 04/2013 - 08/2011
2	Hyperhomocysteinemia 10/2012 - 10/2002
2	Acute Coronary Syndrome 03/2008 - 09/2004
2	Myocardial Infarction 10/2004 - 09/2004
2	Protein S Deficiency (Deficiency, Protein S) 01/2003 - 05/2002
1	Leukemia 06/2022
1	Neutropenia 01/2022
1	Demyelinating Diseases (Demyelinating Disease) 01/2022
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2021
1	Congenital Heart Defects (Congenital Heart Defect) 11/2021
1	COVID-19 04/2021
1	Bronchiolitis 01/2021
1	Cytopenia 05/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2020
1	Basal Cell Carcinoma (Rodent Ulcer) 05/2020
1	Virus Diseases (Viral Diseases) 05/2020
1	Cerebral Hemorrhage 01/2020
1	Plasma Cell Leukemia 01/2020
1	Second Primary Neoplasms (Neoplasms, Second) 01/2020
1	Heart Failure 01/2020

Drug/Important Bio-Agent (IBA)

13	factor V LeidenIBA 10/2013 - 05/2002
12	Prothrombin (Factor II)IBA 10/2013 - 05/2002
10	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2008
9	AnticoagulantsIBA 01/2019 - 10/2004
8	Protein CIBA 10/2013 - 05/2002
7	AntithrombinsIBA 10/2013 - 05/2002
6	Biomarkers (Surrogate Marker)IBA 10/2022 - 04/2008
6	Protein SIBA 04/2014 - 10/2002
5	ruxolitinibIBA 06/2022 - 08/2019
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 03/2012
5	Inosine Triphosphate (ITP)IBA 12/2021 - 01/2020
5	Hydroxyurea (Hydrea)FDA LinkGeneric 05/2020 - 05/2012
4	Dexamethasone (Maxidex)FDA LinkGeneric 10/2022 - 01/2020
4	Thrombopoietin ReceptorsIBA 01/2021 - 01/2018
4	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2019 - 10/2004
4	Oral ContraceptivesIBA 10/2012 - 01/2003
4	DNA (Deoxyribonucleic Acid)IBA 12/2011 - 01/2010
3	elotuzumabIBA 10/2022 - 01/2021
3	Lenalidomide (CC 5013)FDA Link 10/2022 - 01/2021
3	COVID-19 VaccinesIBA 04/2021 - 01/2021
3	Pharmaceutical PreparationsIBA 05/2020 - 08/2006
3	Biological ProductsIBA 08/2009 - 01/2006
2	eltrombopag FDA Link 12/2021 - 01/2021
2	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2016
2	Messenger RNA (mRNA)IBA 01/2021 - 02/2005
2	Alkylating AgentsIBA 01/2021 - 01/2007
2	Vitamin K FDA Link 01/2020 - 03/2008
2	Antiphospholipid AntibodiesIBA 10/2012 - 06/2008
2	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 05/2010 - 04/2009
2	Hormones (Hormone)IBA 08/2009 - 02/2005
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2008 - 08/2006
2	Fluorouracil (Carac)FDA LinkGeneric 11/2008 - 08/2006
2	Cisplatin (Platino)FDA LinkGeneric 10/2006 - 08/2006
2	Heparin (Liquaemin)FDA LinkGeneric 10/2004 - 02/2003
1	carfilzomibIBA 03/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2022
1	ThromboxanesIBA 01/2022
1	CuprizoneIBA 01/2022
1	Imatinib Mesylate (Gleevec)FDA Link 12/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2021
1	SteroidsIBA 01/2021
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021
1	Janus KinasesIBA 05/2020
1	Janus Kinase InhibitorsIBA 05/2020
1	InterferonsIBA 05/2020

Therapy/Procedure

19	Therapeutics 06/2022 - 01/2005
8	Drug Therapy (Chemotherapy) 01/2020 - 09/2003
3	Radiotherapy 02/2011 - 10/2004
3	Neoadjuvant Therapy 11/2008 - 09/2003
2	Salvage Therapy 03/2022 - 01/2021
2	Deep Brain Stimulation 03/2015 - 12/2014
1	Fontan Procedure (Fontan Operation) 11/2021
1	Injections 04/2021
1	Stem Cell Transplantation 01/2021
1	Heart-Assist Devices 01/2020
1	Splenectomy 01/2020